First in vivo evaluation of particulate nasal dry powder vaccine formulations containing ovalbumin in mice.

R. Scherließ,M. Mönckedieck,K. Young,Sabrina Trows,Simon Buske,S. Hook
DOI: https://doi.org/10.1016/j.ijpharm.2015.01.015
IF: 6.51
2015-02-20
International Journal of Pharmaceutics
Abstract:
What problem does this paper attempt to address?